MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
2951.71%
Quick Ratio
2951.71%
Cash Ratio
152.74%
Debt to Asset Ratio
5.71%
Unit: Dollar
Assets Breakdown
Short-term investments
Cash and cash equivalents
Prepaid expenses
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Stock appreciation rights
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
11,334,370
3,496,540
1,384,484
1,353,351
Short-term investments
206,396,805
89,509,710
12,502,040
19,266,190
Other receivable
10,912
-
-
-
Prepaid expenses
1,297,590
977,721
967,745
474,628
Total current assets
219,039,677
93,983,971
14,854,269
21,094,169
Other assets
19,500
19,500
21,975
21,975
Total assets
219,059,177
94,003,471
14,876,244
21,116,144
Accounts payable
2,409,190
1,568,944
1,453,102
1,361,911
Accrued expenses
5,011,583
4,861,583
3,736,496
3,772,636
Total current liabilities
7,420,773
6,430,527
5,189,598
5,134,547
Preferred stock value-Preferred Class A
-
-
-
0
Stock appreciation rights
5,080,081
1,060,931
221,107
32,116
Preferred stock value
-
-
-
0
Total liabilities
12,500,854
7,491,458
5,410,705
5,166,663
Common stock, 0.001 par value, 200,000,000 shares authorized, 106,669,846 and 73,333,622 shares issued and outstanding, respectively
106,670
73,333
33,191
33,191
Additional paid-in capital
936,684,992
784,705,878
687,831,786
684,224,232
Accumulated deficit
-730,233,339
-698,267,198
-678,399,438
-668,307,942
Total stockholders equity
206,558,323
86,512,013
9,465,539
15,949,481
Total liabilities and stockholders equity
219,059,177
94,003,471
14,876,244
21,116,144
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Short-term investments
$206,396,805
(971.29%↑ Y/Y)
Cash and cash
equivalents
$11,334,370
(737.50%↑ Y/Y)
Prepaid expenses
$1,297,590
(173.39%↑ Y/Y)
Other receivable
$10,912
Total current assets
$219,039,677
(938.39%↑ Y/Y)
Other assets
$19,500
(-11.26%↓ Y/Y)
Total assets
$219,059,177
(937.40%↑ Y/Y)
Total liabilities and
stockholders equity
$219,059,177
(937.40%↑ Y/Y)
Total stockholders
equity
$206,558,323
(1195.08%↑ Y/Y)
Total liabilities
$12,500,854
(141.95%↑ Y/Y)
Accumulated deficit
-$730,233,339
(-9.27%↓ Y/Y)
Additional paid-in capital
$936,684,992
(36.90%↑ Y/Y)
Total current
liabilities
$7,420,773
(44.53%↑ Y/Y)
Stock appreciation
rights
$5,080,081
(15717.91%↑ Y/Y)
Common stock, 0.001 par
value, 200,000,000...
$106,670
(221.38%↑ Y/Y)
Accrued expenses
$5,011,583
(32.84%↑ Y/Y)
Accounts payable
$2,409,190
(76.90%↑ Y/Y)
Buy us a coffee
RELMADA THERAPEUTICS, INC. (RLMD)
RELMADA THERAPEUTICS, INC. (RLMD)